| 6.64 0.04 (0.61%) | 06-20 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 8.29 | 1-year : | 9.68 |
| Resists | First : | 7.09 | Second : | 8.29 |
| Pivot price | 6.48  |
|||
| Supports | First : | 6.23 | Second : | 5.69 |
| MAs | MA(5) : | 6.51 |
MA(20) : | 6.5 |
| MA(100) : | 7.75  |
MA(250) : | 9.03 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 42.9 |
D(3) : | 37.1 |
| RSI | RSI(14): 52.7 |
|||
| 52-week | High : | 13.32 | Low : | 5.69 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ INGN ] has closed below upper band by 17.7%. Bollinger Bands are 71.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 6.74 - 6.77 | 6.77 - 6.79 |
| Low: | 6.53 - 6.56 | 6.56 - 6.59 |
| Close: | 6.59 - 6.64 | 6.64 - 6.68 |
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Mon, 16 Jun 2025
Inogen (INGN) Stock Coverage Initiated by B. Riley Securities | INGN Stock News - GuruFocus
Mon, 16 Jun 2025
Inogen: Still Breathing, But Margin Pressures Persist (NASDAQ:INGN) - Seeking Alpha
Mon, 16 Jun 2025
Inogen (INGN) Initiated with Buy Rating by B. Riley Analyst | INGN Stock News - GuruFocus
Tue, 10 Jun 2025
Here’s Why Brown Capital Management Small Company Fund Sold Inogen (INGN) in Q1 - Insider Monkey
Thu, 22 May 2025
Needham Upgrades Inogen (INGN) to Buy - MSN
Thu, 22 May 2025
Needham Upgrades Inogen (INGN) - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 27 (M) |
| Shares Float | 24 (M) |
| Held by Insiders | 12.1 (%) |
| Held by Institutions | 73.9 (%) |
| Shares Short | 1,100 (K) |
| Shares Short P.Month | 911 (K) |
| EPS | -1.15 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.36 |
| Profit Margin | -8.1 % |
| Operating Margin | -9.4 % |
| Return on Assets (ttm) | -6.2 % |
| Return on Equity (ttm) | -14.2 % |
| Qtrly Rev. Growth | 5.5 % |
| Gross Profit (p.s.) | 5.82 |
| Sales Per Share | 12.64 |
| EBITDA (p.s.) | -0.38 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -6 (M) |
| Levered Free Cash Flow | -17 (M) |
| PE Ratio | -5.78 |
| PEG Ratio | 0 |
| Price to Book value | 0.9 |
| Price to Sales | 0.52 |
| Price to Cash Flow | -29.13 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|